Memorial University of Newfoundland, Department of Biochemistry, St. John's, Newfoundland, Canada.
Memorial University of Newfoundland, Department of Biochemistry, St. John's, Newfoundland, Canada.
Biochim Biophys Acta Gen Subj. 2017 Aug;1861(8):1960-1969. doi: 10.1016/j.bbagen.2017.05.010. Epub 2017 May 12.
Pyruvate dehydrogenase (PDHC) and α-ketoglutarate dehydrogenase complex (KGDHC) are important sources of reactive oxygen species (ROS). In addition, it has been found that mitochondria can also serve as sinks for cellular hydrogen peroxide (HO). However, the ROS forming and quenching capacity of liver mitochondria has never been thoroughly examined. Here, we show that mouse liver mitochondria use catalase, glutathione (GSH), and peroxiredoxin (PRX) systems to quench ROS. Incubation of mitochondria with catalase inhibitor 3-amino-1,2,4-triazole (triazole) induced a significant increase in pyruvate or α-ketoglutarate driven O/HO formation. 1-Choro-2,4-dinitrobenzene (CDNB), which depletes glutathione (GSH), elicited a similar effect. Auranofin (AF), a thioredoxin reductase-2 (TR2) inhibitor which disables the PRX system, did not significantly change O/HO formation. By contrast catalase, GSH, and PRX were all required to scavenging extramitochondrial HO. In this study, the ROS forming potential of PDHC, KGDHC, Complex I, and Complex III was also profiled. Titration of mitochondria with 3-methyl-2-oxovaleric acid (KMV), a specific inhibitor for O/HO production by KGDHC, induced a ~86% and ~84% decrease in ROS production during α-ketoglutarate and pyruvate oxidation. Titration of myxothiazol, a Complex III inhibitor, decreased O/HO formation by ~45%. Rotenone also lowered ROS production in mitochondria metabolizing pyruvate or α-ketoglutarate indicating that Complex I does not contribute to ROS production during forward electron transfer from NADH. Taken together, our results indicate that KGDHC and Complex III are high capacity sites for O/HO production in mouse liver mitochondria. We also confirm that catalase plays a role in quenching either exogenous or intramitochondrial HO.
丙酮酸脱氢酶 (PDHC) 和 α-酮戊二酸脱氢酶复合物 (KGDHC) 是活性氧 (ROS) 的重要来源。此外,人们发现线粒体也可以作为细胞过氧化氢 (HO) 的汇。然而,肝线粒体的 ROS 形成和淬灭能力从未被彻底研究过。在这里,我们表明,鼠肝线粒体使用过氧化氢酶、谷胱甘肽 (GSH) 和过氧化物酶 (PRX) 系统来淬灭 ROS。用过氧化氢酶抑制剂 3-氨基-1,2,4-三唑 (三唑) 孵育线粒体可显著增加丙酮酸或 α-酮戊二酸驱动的 O/HO 形成。耗竭谷胱甘肽 (GSH) 的 1-氯-2,4-二硝基苯 (CDNB) 也产生了类似的效果。硫氧还蛋白还原酶-2 (TR2) 抑制剂金诺芬 (AF) 会使 PRX 系统失活,但对 O/HO 形成的影响不大。相反,过氧化氢酶、GSH 和 PRX 都需要清除细胞外的 HO。在这项研究中,还对 PDHC、KGDHC、复合物 I 和复合物 III 的 ROS 形成潜力进行了分析。用 3-甲基-2-氧代戊酸 (KMV) 滴定线粒体,KMV 是 KGDHC 产生 O/HO 的特异性抑制剂,导致在α-酮戊二酸和丙酮酸氧化过程中 ROS 产生减少约 86%和 84%。用复合物 III 抑制剂鱼藤酮滴定,可使 O/HO 形成减少约 45%。鱼藤酮也降低了线粒体代谢丙酮酸或α-酮戊二酸时的 ROS 产生,表明在 NADH 的正向电子传递过程中,复合物 I 不会产生 ROS。总之,我们的结果表明,KGDHC 和复合物 III 是鼠肝线粒体中 O/HO 产生的高容量位点。我们还证实,过氧化氢酶在淬灭外源性或线粒体内部的 HO 方面发挥作用。